At Home Brain Stimulation Studies of Memory and Memory Awareness (remTDCS)

July 9, 2021 updated by: Elizabeth Chua, Brooklyn College of the City University of New York
The main goal of this research is to determine the role of several brain regions in memory processes and cognitive functions. Participants will be remotely supervised via video chat while self-administering tDCS, a form of non-invasive brain stimulation. Before participating in the experiment, participants will be properly trained on use of the remote tDCS device and screened for eligibility. While using the tDCS device, participants will be engaging in tasks that assess different aspects of memory and executive functioning. By using remotely supervised tDCS while participants are completing these cognitive tasks, we will be able to make causal claims about the role of the targeted brain regions in different cognitive processes.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Anticipated)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • New York
      • Brooklyn, New York, United States, 11210
        • Recruiting
        • Brooklyn College
        • Contact:
        • Contact:
        • Principal Investigator:
          • Elizabeth Chua, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • between the ages of 18-35
  • normal or corrected to normal vision
  • fluent in English and speaking English since age 5
  • right handed

Exclusion Criteria:

  • chronic skin disease or medical skin condition
  • unhealed wound or open skin on the scalp, face, neck, or forehead
  • metal or electrode implants (e.g., cochlear implants, pacemakers, metal plates, rods, or screws in their head; for complete detail, see the screening form)
  • seizures or a family history of seizures, or are taking medications with a lowered seizure threshold
  • pregnant or lactating
  • any neurologic or psychiatric diseases
  • certain hair styles (dreadlocks, cornrows, etc) or hair coverings (e.g., wigs, hajibs, etc that will not be removed; note that a request can be made for an experimenter of a specific gender)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: DLPFC stimulation
F3-SO montage or OLE optimized with 2 mA stimulation for up to 30 min during memory and metamemory task.
Low levels of electrical current are applied across the scalp to induce small changes in brain activity. This is done using remote supervision.
Sham Comparator: Sham tDCS
F3-SO montage or OLE optimized with sham stimulation for up to 30 min during memory and metamemory task.
Low levels of electrical current are applied across the scalp to induce small changes in brain activity. This is done using remote supervision.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Memory performance
Time Frame: through study completion, an average of 4 weeks
% Correct on the Memory Task
through study completion, an average of 4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Memory Confidence
Time Frame: through study completion, an average of 4 weeks
Average % Confidence on the Memory Task
through study completion, an average of 4 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Metamemory Accuracy
Time Frame: through study completion, an average of 4 weeks
Calibration and resolution of confidence and accuracy.
through study completion, an average of 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 15, 2021

Primary Completion (Anticipated)

August 31, 2022

Study Completion (Anticipated)

August 21, 2023

Study Registration Dates

First Submitted

February 1, 2021

First Submitted That Met QC Criteria

February 8, 2021

First Posted (Actual)

February 11, 2021

Study Record Updates

Last Update Posted (Actual)

July 12, 2021

Last Update Submitted That Met QC Criteria

July 9, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 42037
  • SC3GM121192 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on remotely supervised transcranial direct current stimulation

Subscribe